Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ann Hematol
Main Authors: Cerchione, Claudio, Peluso, Ilaria, Nappi, Davide, Pareto, Anna Emanuele, Picardi, Marco, Martinelli, Vincenzo, Pane, Fabrizio
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2017
Teme:
Letter to the Editor
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5334413/
https://ncbi.nlm.nih.gov/pubmed/28197723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-017-2938-5
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki